Skip to content
HowShorted

Tonix Pharmaceuticals Holding short interest in 2022

In 2022, Tonix Pharmaceuticals Holding's disclosed short interest ran from 1.95% of shares outstanding on 14 Jan 2022 to 5.84% on 30 Dec 2022, a change of +3.89 percentage points. The year's high was 8.44% on 29 Apr 2022 and its low 1.07% on 15 Nov 2022, averaging 4.61% across 15 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 2.58 days on 29 Apr 2022. Full history: Tonix Pharmaceuticals Holding.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2025 · 2026

Aggregate net short position time series for Tonix Pharmaceuticals Holding in 2022

2022 in figures

Start of year
1.95% (14 Jan 2022)
End of year
5.84% (30 Dec 2022)
Change
+3.89 pp
High
8.44% (29 Apr 2022)
Low
1.07% (15 Nov 2022)
Average
4.61%
Highest days to cover
2.58 (29 Apr 2022)
SEC filings marked
10

Every report in 2022

Tonix Pharmaceuticals Holding short interest in 2022
SettlementShort interestDays to coverFilings since previous
14 Jan 20221.95%1.00
15 Mar 20225.40%1.0010-K filed, results (8-K)
31 Mar 20226.00%1.23
14 Apr 20226.93%1.43
29 Apr 20228.44%2.58
13 May 20227.87%2.3610-Q filed, results (8-K)
15 Aug 20225.81%1.00results (8-K), 10-Q filed, results (8-K)
31 Aug 20225.57%1.00
15 Sep 20224.42%1.00
30 Sep 20222.58%1.00
14 Oct 20222.63%1.00
31 Oct 20222.20%1.00results (8-K)
15 Nov 20221.07%1.0010-Q filed, results (8-K)
30 Nov 20222.39%1.00
30 Dec 20225.84%1.17

See also: Tonix Pharmaceuticals Holding's full history · most shorted US stocks of 2022 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.